Gila Therapeutics has a total of 24 patents globally, out of which none have been granted. Of these 24 patents, more than 70% patents are active. The USA is where Gila Therapeutics has filed the maximum number of patents. Parallelly, the United States seems to be the main focused R&D center of Gila Therapeutics and is also the origin country of the firm.
Gila Therapeutics was founded in the year 2014 by Andres Acosta and Tom Vasicek. The company is a clinical-stage pharmaceutical firm developing a therapy for obesity.
Do read about some of the most popular patents of Gila Therapeutics which have been covered by us in this article and also you can find Gila Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Gila Therapeutics patent portfolio.
How many patents does Gila Therapeutics have?
Gila Therapeutics has a total of 24 patents globally. These patents belong to 5 unique patent families. Out of 24 patents, 17 patents are active.
How Many Patents did Gila Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
How many Gila Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Gila Therapeutics File in Different Countries?
Countries in which Gila Therapeutics Filed Patents
| Country | Patents |
| United States Of America | 5 |
| Japan | 2 |
| Canada | 2 |
| Mexico | 2 |
| Brazil | 2 |
| Australia | 2 |
| Europe | 2 |
| Israel | 2 |
Where are Research Centres of Gila Therapeutics Patents Located?
The R&D Centres of patents filed by Gila Therapeutics is in the US.
Most Cited Gila Therapeutics Patent
US20190231850A1 is the most popular patent in the Gila Therapeutics portfolio. It has received 3 citations so far.
List of Gila Therapeutics Patents
| Gila Therapeutics Patents | Title |
| US20230084803A1 | Compositions And Methods For Treating Metabolic Diseases |
| US20220143146A1 | Peptide Yy Pharmaceutical Formulations, Compositions, And Methods |
| US20210308223A1 | Peptide Yy Pharmaceutical Formulations, Compositions, And Methods |
| US20190231850A1 | Peptide Yy Pharmaceutical Formulations, Compositions, And Methods |
| EP3743092A4 | Peptide Yy Pharmaceutical Formulations, Compositions, And Methods |
| EP3737379A4 | Compositions And Methods For Treating Metabolic Diseases |
| WO2023283393A3 | Methods For Inducing Satiety And Treating Metabolic Disorders |
| WO2022272019A8 | Methods And Kits For Inducing Satiety And Treating Metabolic Disorders |
| WO2023283392A1 | Compositions And Methods For Activating A Neural Receptor |
| AU2019211322A1 | Peptide Yy Pharmaceutical Formulations, Compositions, And Methods |
| CA3087733A1 | Peptide Yy Pharmaceutical Formulations, Compositions, And Methods |
| CA3087077A1 | Compositions And Methods For Treating Metabolic Diseases |
| BR112020014596A2 | Pharmaceutical Formulations, Compositions And Methods Of Peptide Yy |
| MX2020007410A | Peptide Yy Pharmaceutical Formulations, Compositions, And Methods. |
| MX2020007167A | Compositions And Methods For Treating Metabolic Diseases. |
| IL276169A | Peptide Yy Pharmaceutical Formulations, Compositions, And Methods |
| IL275767A | Compositions And Methods For Treating Metabolic Diseases |
| US20190224280A1 | Compositions And Methods For Treating Metabolic Diseases |
| WO2019147650A1 | Peptide Yy Pharmaceutical Formulations, Compositions, And Methods |
| WO2019139934A1 | Compositions And Methods For Treating Metabolic Diseases |
| AU2019206391A1 | Compositions And Methods For Treating Metabolic Diseases |
| JPWO2019147650A5 | Peptide Yy Pharmaceutical Formulations, Compositions And Methods |
| JP2021510145A | Compositions And Methods For Treating Metabolic Disorders |
| BR112020013733A2 | Compositions And Methods To Treat Metabolic Diseases |
What are Gila Therapeutics’ key innovation segments?
What Technologies are Covered by Gila Therapeutics?
The chart below distributes patents filed by Gila Therapeutics